Ebola virus (EBOV), a member of the Orthoebolavirus genus, causes Ebola virus disease (EVD), a severe and often fatal illness in humans. Rapid and accurate detection of Ebola virus infection is critical for early diagnosis, outbreak control, and patient management. Among diagnostic tools, enzyme-linked immunosorbent assay (ELISA) kits play an important role by enabling detection of viral antigens or antibodies specific to Ebola virus in various biological samples.

Applications and Sample Types

Ebola virus ELISA kits are employed for qualitative detection in biological research and diagnostic settings with sample types including undiluted human serum, plasma, tissue homogenates, and secretions. Some kits are specifically developed to detect Ebola virus IgM antibodies, which are indicative of recent infection, while others target viral antigens to diagnose early-stage infection.

Sensitivity, Specificity, and Performance

Analytical validation studies have demonstrated that Ebola virus ELISA kits have high sensitivity, detecting antigen concentrations as low as nanogram levels, and show strong specificity for Ebola virus subtypes including Zaire, Reston, and Sudan. Clinical sensitivity evaluated with plasma samples from infected individuals showed detection rates up to approximately 85%, with specificity exceeding 97%. Coefficients of variation (CV) for intra- and inter-assay reproducibility are typically below 15%, assuring assay precision.

The Ebola virus ELISA kit is a critical tool in the rapid detection and diagnosis of Ebola virus infection. Its reliable sensitivity and specificity, combined with the capacity to test a variety of biological samples, make it invaluable in clinical diagnostics, epidemiological surveillance, and research on Ebola virus disease.